Sphera Funds Management Ltd. Vir Biotechnology, Inc. Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
A detailed history of Sphera Funds Management Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 90,855 shares of VIR stock, worth $464,269. This represents 0.15% of its overall portfolio holdings.
Number of Shares
90,855
Previous 581,829
84.38%
Holding current value
$464,269
Previous $4.27 Million
86.23%
% of portfolio
0.15%
Previous 0.88%
Shares
4 transactions
Others Institutions Holding VIR
# of Institutions
255Shares Held
92.6MCall Options Held
257KPut Options Held
261K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$85.3 Million0.99% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$84 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$65.4 Million0.0% of portfolio
-
State Street Corp Boston, MA5.73MShares$29.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.68MShares$13.7 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $678M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...